219 related articles for article (PubMed ID: 33846894)
21. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
Birgül K; Yıldırım Y; Karasulu HY; Karasulu E; Uba AI; Yelekçi K; Bekçi H; Cumaoğlu A; Kabasakal L; Yılmaz Ö; Küçükgüzel ŞG
Eur J Med Chem; 2020 Dec; 208():112841. PubMed ID: 32998089
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases.
Wang J; Lou P; Henkin J
J Cell Biochem; 2000 Apr; 77(3):465-73. PubMed ID: 10760954
[TBL] [Abstract][Full Text] [Related]
24. Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors.
Vyas VK; Ghate M; Goel A
J Mol Graph Model; 2013 May; 42():17-25. PubMed ID: 23507201
[TBL] [Abstract][Full Text] [Related]
25. The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study.
Luo L; Wang Q; Liao Y
Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621970
[TBL] [Abstract][Full Text] [Related]
26. mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations.
Huang Q; Lai T; Wang Q; Luo L
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630311
[TBL] [Abstract][Full Text] [Related]
27. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
Ibrahim MAA; Abdelrahman AHM; Hassan AMA
Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
[TBL] [Abstract][Full Text] [Related]
29. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
Sharma A; Thelma BK
J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
[TBL] [Abstract][Full Text] [Related]
30. MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox state.
Frottin F; Bienvenut WV; Bignon J; Jacquet E; Vaca Jacome AS; Van Dorsselaer A; Cianferani S; Carapito C; Meinnel T; Giglione C
Oncotarget; 2016 Sep; 7(39):63306-63323. PubMed ID: 27542228
[TBL] [Abstract][Full Text] [Related]
31. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
Saxena S; Durgam L; Guruprasad L
J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
[TBL] [Abstract][Full Text] [Related]
32. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
Rathi E; Kumar A; Kini SG
J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
[TBL] [Abstract][Full Text] [Related]
33. Development of pharmacophore model to identify potential DNA gyrase inhibitors.
Jakhar R; Khichi A; Kumar D; Sura K; Bhoomika ; Dangi M; Chhillar AK
J Biomol Struct Dyn; 2023 Nov; 41(19):10125-10135. PubMed ID: 36473713
[TBL] [Abstract][Full Text] [Related]
34. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening.
Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J
Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024
[TBL] [Abstract][Full Text] [Related]
37. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
[TBL] [Abstract][Full Text] [Related]
38. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
39. Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.
Berinyuy E; Soliman MES
Interdiscip Sci; 2017 Sep; 9(3):406-418. PubMed ID: 27165479
[TBL] [Abstract][Full Text] [Related]
40. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
Jade DD; Pandey R; Kumar R; Gupta D
J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
